A detailed history of Eam Investors, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Eam Investors, LLC holds 260,045 shares of CDXC stock, worth $1.6 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
260,045
Previous 398,788 34.79%
Holding current value
$1.6 Million
Previous $2.45 Million 34.8%
% of portfolio
0.21%
Previous 0.45%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
N/A
-138,743 Reduced 34.79%
260,045 $1.6 Million
Q2 2025

Aug 12, 2025

BUY
$5.42 - $7.08 $1.39 Million - $1.81 Million
255,740 Added 178.78%
398,788 $2.45 Million
Q1 2025

May 12, 2025

BUY
$5.26 - $8.55 $12,729 - $20,691
2,420 Added 1.72%
143,048 $987,000
Q4 2024

Feb 13, 2025

BUY
$3.25 - $7.72 $457,041 - $1.09 Million
140,628 New
140,628 $746,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $420M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.